Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
3.590
-0.060 (-1.64%)
At close: Mar 24, 2026, 4:00 PM EDT
3.590
0.00 (0.00%)
After-hours: Mar 24, 2026, 4:25 PM EDT
Whitehawk Therapeutics Market Cap
Whitehawk Therapeutics has a market cap or net worth of $169.44 million as of March 24, 2026. Its market cap has increased by 89.86% in one year.
Market Cap
169.44M
Enterprise Value
23.74M
1-Year Change
89.86%
Ranking
Category
Stock Price
$3.59
Market Cap Chart
Since August 27, 2021, Whitehawk Therapeutics's market cap has decreased from $540.80M to $169.44M, a decrease of -68.67%. That is a compound annual growth rate of -22.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 169.44M | 48.56% |
| Dec 31, 2025 | 114.05M | 46.67% |
| Dec 31, 2024 | 77.76M | 56.96% |
| Dec 29, 2023 | 49.54M | -84.17% |
| Dec 30, 2022 | 312.99M | -37.97% |
| Dec 31, 2021 | 504.59M | -6.70% |
| Aug 27, 2021 | 540.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caribou Biosciences | 175.88M |
| Connect Biopharma Holdings | 175.54M |
| MacroGenics | 173.51M |
| NeOnc Technologies Holdings | 170.87M |
| Adagene | 170.14M |
| Fennec Pharmaceuticals | 169.26M |
| Canton Strategic Holdings | 167.44M |
| Protalix BioTherapeutics | 166.47M |